Sonia T Henriques
Overview
Explore the profile of Sonia T Henriques including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Menzel J, Young R, Benfield A, Scott J, Wongsomboon P, Cudlman L, et al.
Nat Commun
. 2023 Jul;
14(1):3940.
PMID: 37402773
Fatty acid isomers are responsible for an under-reported lipidome diversity across all kingdoms of life. Isomers of unsaturated fatty acids are often masked in contemporary analysis by incomplete separation and...
2.
Wang C, Huang Y, Shabbir F, Pham H, Lawrence N, Benfield A, et al.
Peptides
. 2023 Jun;
167:171049.
PMID: 37390898
Bacteriocins are a large family of bacterial peptides that have antimicrobial activity and potential applications as clinical antibiotics or food preservatives. Circular bacteriocins are a unique class of these biomolecules...
3.
Liu X, Henriques S, Craik D, Chan L
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982972
Gomesin is a cationic antimicrobial peptide which is isolated from the haemocytes of the Brazilian tarantula Acanthoscurria gomesiana and can be produced chemically by Fmoc solid-phase peptide synthesis. Gomesin exhibits...
4.
Nadal-Bufi F, Chan L, Mohammad H, Mason J, Salomon C, Lai A, et al.
Cell Mol Life Sci
. 2022 Nov;
79(12):606.
PMID: 36436181
Lactate dehydrogenase 5 (LDH5) is overexpressed in many cancers and is a potential target for anticancer therapy due to its role in aerobic glycolysis. Small-molecule drugs have been developed as...
5.
Dias S, Pinto S, Silva-Herdade A, Cheneval O, Craik D, Coutinho A, et al.
J Antimicrob Chemother
. 2022 Sep;
77(12):3256-3264.
PMID: 36171717
Background: Infections caused by bacterial biofilms are very difficult to treat. The use of currently approved antibiotics even at high dosages often fails, making the treatment of these infections very...
6.
Edwards I, Henriques S, Blaskovich M, Elliott A, Cooper M
Biochim Biophys Acta Gen Subj
. 2022 May;
1866(8):130156.
PMID: 35523364
Arenicin-3 is an amphipathic β-hairpin antimicrobial peptide that is produced by the lugworm Arenicola marina. In this study, we have investigated the mechanism of action of arenicin-3 and an optimized...
7.
Philippe G, Mittermeier A, Lawrence N, Huang Y, Condon N, Loewer A, et al.
ACS Chem Biol
. 2021 Feb;
16(2):414-428.
PMID: 33533253
Peptides are being developed as targeted anticancer drugs to modulate cytosolic protein-protein interactions involved in cancer progression. However, their use as therapeutics is often limited by their low cell membrane...
8.
Philippe G, Craik D, Henriques S
Drug Discov Today
. 2021 Feb;
26(6):1521-1531.
PMID: 33524603
Peptides are gaining increasing attention as therapeutics to target intracellular protein-protein interactions that are involved in disease progression. In this review, we discuss how peptides that are able to bind...
9.
Skalska J, Andrade V, Cena G, Harvey P, Gaspar D, Mello E, et al.
J Med Chem
. 2020 Aug;
63(17):9391-9402.
PMID: 32787086
Available treatments for invasive fungal infections have limitations, including toxicity and the emergence of resistant strains. Therefore, there is an urgent need for alternative solutions. Because of their unique mode...
10.
Sorolla A, Wang E, Golden E, Duffy C, Henriques S, Redfern A, et al.
Oncogene
. 2019 Oct;
39(6):1167-1184.
PMID: 31636382
In molecular cancer therapeutics only 10% of known cancer gene products are targetable with current pharmacological agents. Major oncogenic drivers, such as MYC and KRAS proteins are frequently highly overexpressed...